Prospective, randomized, double-blinded, placebo-controlled clinical investigation of advanced heart failure patients treated with the HM3 with two different antithrombotic regimens: vitamin K antagonist with aspirin versus vitamin K antagonist with placebo
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/heart-blood.jpg)
Description
This clinical investigation is a prospective, randomized, double-blinded, placebo-controlled study of advanced heart failure patients treated with the HM3 with two different antithrombotic regimens: vitamin K antagonist with aspirin versus vitamin K antagonist with placebo. The objective of this investigation is to study the safety and efficacy of an anti-platelet-free antithrombotic regimen in patients with advanced heart failure treated with the HM3 LVAS..
Details
Adult
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Andreas Brieke](https://som.ucdenver.edu/FIMS/Content/faculty/4733/CU-Doctors-4733.jpg)
Andreas Brieke
Study ID
Protocol Number: 20-0254
More information available at ClinicalTrials.gov: NCT04069156
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers